InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,543.22
(
1.61%
)
US TECH 100
19,002.00
(
2.66%
)
Dow Jones
40,563.06
(
1.39%
)
Brent Oil
80.39
(
-0.12%
)
Bitcoin
58,141.60
(
1.04%
)
Post# of 252897
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: None

Thursday, 04/17/2008 5:59:35 PM

Thursday, April 17, 2008 5:59:35 PM

Post# of 252897
Teva Pharm: Copaxone significantly reduced brain atrophy and tissue loss over five years in treatment-naive relapsing-remitting multiple sclerosis patients (46.36 -0.19) -Update-

http://biz.yahoo.com/bw/080417/20080417006156.html?.v=1

Co announces final results from a five-year comparative imaging study examining the long-term effect of disease-modifying therapies in treatment-naive, early relapsing-remitting multiple sclerosis patients, demonstrated that Copaxone treated patients experienced significantly less brain tissue loss, as measured by percent change in brain volume, compared with patients on other DMTs.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up